PCM
MJN

Portolan Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Portolan Capital Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,665
Closed -$211K – 163
2013
Q2 		$211K Buy
+2,665
New +$214K 0.06% 154

Other funds holding MJN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Portolan Capital Management's MJN Position: Q3 2013 in Review

Portolan Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q3 2013, closing a stake of 2,665 shares — an estimated $211K sold.

Portolan Capital Management first reported a position in MJN in Q2 2013 and held it in 1 quarter. The position peaked at $211K in Q2 2013. 450 funds tracked by Wall St. Rank hold MJN as of Q3 2013.

  • Portolan Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q3 2013 after selling out during the quarter.
  • Portolan Capital Management sold 2,665 Mead Johnson Nutrition Company shares in Q3 2013, an estimated $211K.
  • Portolan Capital Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 1 quarter.
  • Portolan Capital Management's Mead Johnson Nutrition Company position peaked at $211K in Q2 2013.
  • 450 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2013.

Based on Portolan Capital Management's 13F filing for Q3 2013, filed 8 Nov 2013.